Oct 16, 2018
Altus Formulation is an R&D focused pharmaceutical development company with a suite of proprietary drug delivery technologies and a rapidly growing portfolio of co-development and licensing agreements with a range of global partners. Altus is seeking a Head of... read more
Mar 5, 2018
MONTREAL, QC / ACCESSWIRE / March 5, 2018 / Recipharm, the contract development and manufacturing organisation (CDMO), has signed a licensing agreement with Altus Formulation Inc., a Canadian drug development company, to allow its customers to access new drug delivery... read more
Jan 19, 2017
Altus is pleased to present FLEXITABTM, an innovative and commercially validated technology platform providing novel, value added life-cycle management opportunities through Safer UseTM breakable, extended release (ER) tablets. Conventional ER tablets may ‘dose dump’... read more
May 18, 2016
Altus Formulation Inc. a Quebec based drug development company, leveraging its patented delivery technologies to develop novel Safer to UseTM formulations for its partners and their patients is pleased to announce the allowance of its first FLEXITABTM patent in Europe... read more
Sep 9, 2015
Next-Generation Tablet Formulation Resists Physical Manipulation and Extraction of Hydrocodone In Vitro Data Supports Further Human Abuse Liability Studies LAS VEGAS, NV – September 9, 2015 (GLOBAL NEWSWIRE) – Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a... read more
Jul 27, 2015
MORRISTOWN, N.J., July 27, 2015 (GLOBAL NEWSWIRE) – Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced positive results from Category 1 (in vitro) abuse deterrence studies with ZX007, utilizing Altus Formulation’s... read more
May 20, 2015
Montreal, Quebec, Canada Altus Formulation Inc. a Quebec – based drug formulation and development company, leveraging it’s patented drug delivery technologies to develop Safer to UseTM formulations for its partners and their patients today announced the issuance of... read more
May 5, 2015
MORRISTOWN, N.J., May 05, 2015 (BUSINESS WIRE) — Pernix Therapeutics Holdings, Inc. PTX, +0.94% a specialty pharmaceutical company, today announced the successful completion of a human pharmacokinetic equivalence study with ZX007, an innovative abuse deterrent... read more
Feb 2, 2015
Altus Formulation Inc. Montreal Monday February 2nd. 09:00 Altus Formulation Inc. is a Canadian Drug Formulation and Development Company, leveraging our patented drug delivery technologies to develop Safer to UseTM formulations for our partners and their patients.... read more
Jan 20, 2015
Altus Formulation Inc. Montreal Altus Formulation Inc. a Quebec – based drug formulation and development company, leveraging it’s patented drug delivery technologies to develop Safer to UseTM formulations for its partners and their patients is pleased to announce the... read more
